Investigation of the patient with pleural effusion (2)
Given the fact that culture of pleural fluid (using Lowenstein medium) has only 36.6% sensitivity for diagnosis of tuberculous pleural effusion versus 79.8% sensitivity obtained with the more invasive modality of histological identification of caseating granuloma,1 among the non-invasive ‘special tests’ for evaluation of pleural effusion,2 mention should also have been made of adenosine deaminase (ADA)3 and interferon-gamma (IFN-gamma),4 so as to complement strategies such as staining and culture for acid-fast bacilli.2In a systematic review of 63 studies ADA was characterised by positive likelihood ratio 9.03 (95% confidence interval (CI) 7.19 to 11.35), negative likelihood ration 0.10 (95% CI 0.07 to 0.14) for diagnosis of tuberculous pleural effusion.3Correspondingly, in a systematic review of 22 studies, diagnostic accuracy of IFN-gamma was characterised by positive likelihood ration amounting to 23.45 (95% CI 17.31 to 31.78), and negative likelihood ratio 0.11 (95% CI 0.07 to 0.16).4In the setting of tuberculous effusion prevalence of 5%, post-test probability of a negative ADA test has been estimate to be 0.4%, increasing to 2.4% where tuberculous pleural effusion has a 25% prevalence. For INF-gamma, corresponding post-test probabilities are 0.22% and 1.2% respectively.
- © 2009 Royal College of Physicians
References
Investigation of the patient with pleural effusion (2)
We would like to thank Drs Chua, Groth and Jolobe for their letters concerning our article on respiratory investigations in pleural effusion, highlighting the use of pleural fluid adenosine deaminase (ADA) as a potential diagnostic test for suspected TB pleuritis. We agree that pleural fluid ADA is an important, useful and inexpensive diagnostic test for the investigation of patients with a moderate to high probability of TB pleuritis, on the basis of the evidence quoted. Pleural fluid ADA was not included in our article due to varying availability in the UK of this test, and constraints on the article length. The majority of chest physicians practise in low prevalence areas in the UK, although there are some areas where this is not the case. Pleural fluid ADA is associated with false positive results (eg pleural infection, rheumatoid pleuritis and malignancy) and in areas of low prevalence such as much of the UK, this limits ADA to being a ‘rule out’ test. We would suggest ADA is restricted to use in lymphocytic effusions in which there is at least a reasonable pretest probability of TB pleuritis. In addition, the diagnosis of TB pleuritis using markers of immune cell activation (ie ADA or interferon-gamma releasing assays) do not achieve specimens on which microbiological sensitivity may be tested. Although data from the USA suggest that the pattern of resistance in TB pleuritis reflects that seen in local pulmonary TB, this may not be helpful in the assessment of resistance in immigrants or recently returned travellers.1In these circumstances, we would suggest pleural biopsy for histology and culture remains the gold standard diagnostic test, conducted either using Abram's needles or under image/thoracoscopic guidance. We would like to thank the authors for their interest in our article.
- © 2009 Royal College of Physicians
Article Tools
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.